The Federal Trade Commission will hold a two-day meeting starting Tuesday (June 14) on drug industry mergers, followed by a meeting Thursday at which FTC will vote on whether to issue a policy statement describing the commission’s intent to examine drug rebates. This week also brings congressional markups of FDA user fee legislation and FDA appropriations, plus a hearing on the administration’s response to the pandemic. Plus, FDA advisers will vote Tuesday and Wednesday on whether to recommend authorizing messenger-RNA...